BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31857797)

  • 1. The burden of comorbidities in pulmonary arterial hypertension.
    Lang IM; Palazzini M
    Eur Heart J Suppl; 2019 Dec; 21(Suppl K):K21-K28. PubMed ID: 31857797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis.
    Poms AD; Turner M; Farber HW; Meltzer LA; McGoon MD
    Chest; 2013 Jul; 144(1):169-176. PubMed ID: 23348820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase 5 inhibitors for pulmonary hypertension.
    Barnes H; Brown Z; Burns A; Williams T
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012621. PubMed ID: 30701543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines.
    Dinarti LK; Anggrahini DW; Lilyasari O; Siswanto BB; Hartopo AB
    Glob Heart; 2021 Apr; 16(1):23. PubMed ID: 34040936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension.
    Kenny M; Clarke MM; Pogue KT
    J Pharm Pract; 2022 Jun; 35(3):437-444. PubMed ID: 33084500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why there is a need to discuss pulmonary hypertension other than pulmonary arterial hypertension?
    Papathanasiou A; Nakos G
    World J Crit Care Med; 2015 Nov; 4(4):274-7. PubMed ID: 26557477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
    Gialamas I; Arvanitaki A; Rosenkranz S; John Wort S; Rådegran G; Badagliacca R; Giannakoulas G
    J Heart Lung Transplant; 2024 May; ():. PubMed ID: 38744353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Female gender and pulmonary arterial hypertension: a complex relationship].
    Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
    G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry.
    Kaemmerer H; Gorenflo M; Huscher D; Pittrow D; Apitz C; Baumgartner H; Berger F; Bruch L; Brunnemer E; Budts W; Claussen M; Coghlan G; Dähnert I; D'Alto M; Delcroix M; Distler O; Dittrich S; Dumitrescu D; Ewert R; Faehling M; Germund I; Ghofrani HA; Grohé C; Grossekreymborg K; Halank M; Hansmann G; Harzheim D; Nemes A; Havasi K; Held M; Hoeper MM; Hofbeck M; Hohenfrost-Schmidt W; Jurevičienė E; Gumbienè L; Kabitz HJ; Klose H; Köhler T; Konstantinides S; Köestenberger M; Kozlik-Feldmann R; Kramer HH; Kropf-Sanchen C; Lammers A; Lange T; Meyn P; Miera O; Milger-Kneidinger K; Neidenbach R; Neurohr C; Opitz C; Perings C; Remppis BA; Riemekasten G; Scelsi L; Scholtz W; Simkova I; Skowasch D; Skride A; Stähler G; Stiller B; Tsangaris I; Vizza CD; Vonk Noordegraaf A; Wilkens H; Wirtz H; Diller GP; Grünig E; Rosenkranz S
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32414075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension.
    Montani D; Günther S; Dorfmüller P; Perros F; Girerd B; Garcia G; Jaïs X; Savale L; Artaud-Macari E; Price LC; Humbert M; Simonneau G; Sitbon O
    Orphanet J Rare Dis; 2013 Jul; 8():97. PubMed ID: 23829793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Arterial Hypertension: Combination Therapy in Practice.
    Burks M; Stickel S; Galiè N
    Am J Cardiovasc Drugs; 2018 Aug; 18(4):249-257. PubMed ID: 29511993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
    Ruopp NF; Cockrill BA
    JAMA; 2022 Apr; 327(14):1379-1391. PubMed ID: 35412560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Challenges And Advances In The Management Of Systemic Sclerosis-Related Pulmonary Arterial Hypertension (SSc-PAH).
    Argula RG; Ward C; Feghali-Bostwick C
    Ther Clin Risk Manag; 2019; 15():1427-1442. PubMed ID: 31853179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep-related breathing disorders and pulmonary hypertension.
    Adir Y; Humbert M; Chaouat A
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 32747397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial hypertension in patients with sleep apnoea syndrome.
    Bady E; Achkar A; Pascal S; Orvoen-Frija E; Laaban JP
    Thorax; 2000 Nov; 55(11):934-9. PubMed ID: 11050263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary arterial hypertension in adults with congenital heart disease: markers of disease severity, management of advanced heart failure and transplantation.
    Jansen K; Constantine A; Condliffe R; Tulloh R; Clift P; Moledina S; Wort SJ; Dimopoulos K
    Expert Rev Cardiovasc Ther; 2021 Sep; 19(9):837-855. PubMed ID: 34511015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature.
    Sanges S; Yelnik CM; Sitbon O; Benveniste O; Mariampillai K; Phillips-Houlbracq M; Pison C; Deligny C; Inamo J; Cottin V; Mouthon L; Launay D; Lambert M; Hatron PY; Rottat L; Humbert M; Hachulla E
    Medicine (Baltimore); 2016 Sep; 95(39):e4911. PubMed ID: 27684828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry.
    Brown LM; Chen H; Halpern S; Taichman D; McGoon MD; Farber HW; Frost AE; Liou TG; Turner M; Feldkircher K; Miller DP; Elliott CG
    Chest; 2011 Jul; 140(1):19-26. PubMed ID: 21393391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study.
    Rosenkranz S; Channick R; Chin KM; Jenner B; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; McLaughlin VV; Du Roure C; Rubin LJ; Sitbon O; Tapson V; Lang IM
    Eur J Heart Fail; 2022 Jan; 24(1):205-214. PubMed ID: 34806261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan.
    Tamura Y; Kumamaru H; Inami T; Matsubara H; Hirata KI; Tsujino I; Suda R; Miyata H; Nishimura S; Sigel B; Takano M; Tatsumi K;
    JACC Asia; 2022 Jun; 2(3):273-284. PubMed ID: 36338395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.